Subcutaneous versus transvenous implantable cardioverter defibrillator in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
Antônio da Silva MenezesIzadora Caiado OliveiraAndré Maroccolo de SousaRicardo Figueiredo Paro PiaiVinícius Martins Rodrigues OliveiraPublished in: Cardiovascular diagnosis and therapy (2024)
In HCM patients, S-ICDs were associated with a lower incidence of device-associated problems than TV-ICDs. AS and IAS incidence rates were similar between groups. These findings may assist clinicians in determining the most suitable device for treating patients with HCM.